Pancreas Cancer News and Archives
	Data from Phase I Trial of Oncophage Cancer Vaccine in Pancreatic Cancer Highlighted at European Cancer Conference -ECCO 12 September 22, 2003 Antigenics Inc., the world leader in heat shock protein technology, announced results from a Phase I clinical trial of the company's personalized cancer vaccine Oncophage® (HSPPC-96) in patients with nonmetastatic pancreatic cancer, which were highlighted today in an oral presentation at the annual European Cancer Conference (ECCO 12) as well as in a press release issued by the Federation of European Cancer Societies. ...full article
	For educational purposes only; not to be relied upon Please read Pancreatica Disclaimer
	Home | In The News | Links | Newswire | Donations FAQ | Clinical Trials Database | Research Resources | About Us
	webmaster
	©2000-2008 Pancreatica.org - All Rights Reserved www.pancreatica.org